Medication:
Dosage:
Enter the weight(in kg):
MISCELLANEOUS MEDICATIONS |
||
---|---|---|
MEDICATION | DOSAGE, ROUTE, FREQUENCY | INDICATIONS |
Acepromazine (10 mg/ml) | 10 to 20 mg, IV, once | Sedation; relaxation of cervix prior to embryo transfer |
Aminocaproic acid (Amicar®) (250 mg/ml) |
![]() |
Blocks plasminogen; anti-fibrinolytic (management of ruptured uterine artery) |
Benztropine (Cogentin®) (1 mg/ml) | 8 mg, IV, once | Treatment of priapism in stallions or geldings (administer early in course of disease) |
Cabergoline* | 2 to 3 mg, PO, q 12h - q 24h for 500 kg mare | Suppression of lactation |
Calcium gluconate solution (23% solution) | Add 100 to 150 mls to 1 liter of LRS; administer intravenously over 45 to 60 minutes | Adjunct treatment for retained placenta in hypocalcemic mares |
Cerumene™ (Squalane 25% solution)* | Topical application | Cerumenolytic agent; used to clean out clitoral sinuses if bacterial or fungal organisms are present and a potential nidus for subsequent reinfection |
Clenbuterol (Ventipulmin®) (72.5 µg/ml) * |
![]() |
Tocolytic agent (blocks uterine contractions) |
Dexamethasone (2 mg/ml) | 30 to 50 mg, IV or IM, once at time of mating or insemination | Anti-inflammatory; management of persistent mating induced endometritis |
Diazepam (Valium®) (5 mg/ml) |
![]() |
Reduce anxiety in stallions with ejaculation problems |
Firocoxib (Equioxx®) (20 mg/ml; injectable) (paste formulation in calibrated oral syringe and 57 mg tablet also available) |
![]() |
NSAID; selective COX-2 inhibitor; may be used in treatment of placentitis to reduce inflammation |
Fluconazole (200 mg/tablet) |
![]() |
Antifungal agent |
Flunixin meglumine (Banamine®) (50 mg/ml) (paste formulation in calibrated oral syringe also available) |
![]() |
NSAID; anti-inflammatory, anti-prostaglandin; analgesic; administered prior to transfer of an embryo; treatment of placentitis |
Imipramine (50 mg/tablet) |
![]() |
Chemical ejaculation of stallions; lowers the ejaculation threshold |
Itraconazole* |
![]() |
Antifungal agent |
Meclofenamic Acid (Arquel®)* |
![]() |
Prostaglandin inhibitor potentially used as adjunct therapy in embryo transfer |
Mycobacterium cell wall fraction immunostimulant (Settle™) (1.5 ml vial) * | 1.5 mls via intrauterine infusion or intravenous injection during early estrus (repeat as needed) | Immunostimulant; administered to mares with endometritis caused by Streptococcus equi subsp. zooepidemicus; therapeutic goal is to enhance the innate humoral immune response in affected mares |
N-Butylscopolammonium bromide (Buscopan®) (20 mg/ml) |
![]() |
Relaxation of rectal musculature (decrease rectal pressure) |
N-Butylscopolammonium cream or gel (Buscopan®) | Topical cream or gel | Cervical relaxation; gel can be made by combining 5 mls of Buscopan® and 15 mls of sterile obstetrical lubricant or DMSO gel; applied to outside of cervix and within cervical lumen |
Naloxone (Narcan®)* |
![]() |
Postpartum hemorrhage |
Pentoxifylline (400 mg/tablet) * |
![]() |
Management of placentitis |
Pergolide mesylate (Prascend®) (1 mg/tablet) |
![]() |
Treatment of Equine Cushing’s Disease; suppression of lactation |
Perphenazine (Trifafon®)* |
![]() |
Fescue toxicosis |
Phenylephrine HCL (0.25 %) (Preparation H®) | Topical as needed | Vasoconstrictive agent; topical treatment for bleeding vaginal vericose veins |
Propanetheline bromide | 30 mg, IV, once | Rectal relaxation; wait 5 to 10 minutes after administration prior to palpation |
Reserpine (Serpasil®)* | 2.5 mg, PO, q 24h for 7 to 10 days | Management of agalactia, behavioral modification |
Sodium Bicarbonate (8.4%) | 10 to 20 mls added to aminoglycoside antibiotic prior to intrauterine infusion | Used to balance pH of aminoglycoside antibiotics (i.e. gentamicin) |
Xylazine (100 mg/ml) |
![]() |
Chemical ejaculation of stallions; sedation |
*medication reported to be used at other facilities; not in use at CSU
Adobe PDF Reader is required to download and view the PDF
Click here to download